Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

HSCA Statement on FDA Drug Shortages Task Force Report

October 29, 2019 by Brigid Hasson 2019 Press Releases 0 comments

Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement regarding the recent report by the Food and Drug Administration (FDA) Drug Shortages Task Force on drug shortages:

“Ongoing critical prescription drug shortages jeopardize patient access to essential medications. As FDA has noted, the causes of drug shortages are complex and multifactorial, requiring an all-hands-on-deck, multi-stakeholder solution. HSCA and its member group purchasing organizations (GPOs) are on the front lines of helping providers prevent and mitigate drug shortages, working collaboratively with hospitals, physicians, manufacturers, distributors, and government agencies to ensure that providers and patients have access to the life-saving drugs they need.

Click here to read the full release.

Prev
Next

Related Posts

HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
October 5, 2020

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ethylene Oxide Sterilization of Medical Devices
December 12, 2019

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Letter to the House Committee on Energy and Commerce
July 30, 2020

Dear Chairman Pallone and Ranking Member Walden: On behalf of the Healthcare...

Learn more
HSCA Releases Third Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
March 24, 2020

Washington, DC (March 24, 2020) – The Healthcare Supply Chain Association (HSCA),...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on President Biden’s Executive Order on America’s Supply Chains
    February 25, 2021
  • HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
    February 5, 2021